Two-mAb cocktail protects macaques against the Makona variant of Ebola virus

Science Translational Medicine

Volumn 8, Issue 329, 2016, Pages

  Qiu, Xiangguo ^a,b   Audet, Jonathan ^a   Lv, Ming ^c   He, Shihua ^a,b   Wong, Gary ^b,i   Wei, Haiyan ^b,d   Luo, Longlong ^c   Fernando, Lisa ^b   Kroeker, Andrea ^a,b   Bovendo, Hugues Fausther ^b   Bello, Alexander ^b   Li, Feng ^e   Ye, Pei ^e   Jacobs, Michael ^f   Ippolito, Giuseppe ^g   Saphire, Erica Ollmann ^h   Bi, Shengli ^d   Shen, Beifen ^c   Gao, George F ⁱ   Zeitlin, Larry ^j   Feng, Jiannan ^c   Zhang, Boyan ^e   Kobinger, Gary P ^a,b,k   more..

^a UNIVERSITY OF MANITOBA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e Beijing Mabworks Biotech Co Ltd   (China)

^f ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^g NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^h SCRIPPS RESEARCH INSTITUTE   (United States)

ⁱ INSTITUTE OF MICROBIOLOGY   (China)

^j Mapp Biopharmaceutical Inc   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MIL77 1; MONOCLONAL ANTIBODY MIL77 2; MONOCLONAL ANTIBODY MIL77 3; UNCLASSIFIED DRUG; ZMAPP; GLYCOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CHO CELL LINE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESISTANCE; EBOLA HEMORRHAGIC FEVER; FEMALE; INFECTION PREVENTION; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CRICETULUS; EBOLAVIRUS; GUINEA PIG; HAMSTER; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; METABOLISM;

ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; CHROMATOGRAPHY, LIQUID; CRICETINAE; CRICETULUS; EBOLAVIRUS; FEMALE; GUINEA PIGS; HEMORRHAGIC FEVER, EBOLA; MACACA; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE;

EID: 84960417838     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad9875     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention, Outbreaks Chronology: Ebola Virus Disease (available at www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html) (2015).
2. Centers for Disease Control and Prevention, Chronology of Marburg Hemorrhagic Fever Outbreaks, Marburg hemorrhagic fever (Marburg HF) (available at www.cdc.gov/vhf/marburg/resources/outbreak-table.html) (2014).
3. S. Baize, D. Pannetier, L. Oestereich, T. Rieger, L. Koivogui, N. Magassouba, B. Soropogui, M. S. Sow, S. Keïta, H. De Clerck, A. Tiffany, G. Dominguez, M. Loua, A. Traoré, M. Kolié, E. R. Malano, E. Heleze, A. Bocquin, S. Mély, H. Raoul, V. Caro, D. Cadar, M. Gabriel, M. Pahlmann, D. Tappe, J. Schmidt-Chanasit, B. Impouma, A. K. Diallo, P. Formenty, M. Van Herp, S. Günther, Emergence of Zaire Ebola virus disease in Guinea. N. Engl. J. Med. 371, 1418-1425 (2014).
4. J. H. Kuhn, K. G. Andersen, S. Baize, Y. Bào, S. Bavari, N. Berthet, O. Blinkova, J. R. Brister, A. N. Clawson, J. Fair, M. Gabriel, R. F. Garry, S. K. Gire, A. Goba, J.-P. Gonzalez, S. Günther, C. T. Happi, P. B. Jahrling, J. Kapetshi, G. Kobinger, J. R. Kugelman, E. M. Leroy, G. D. Maganga, P. K. Mbala, L. M. Moses, J.-J. Muyembe-Tamfum, M. N'Faly, S. T. Nichol, S. A. Omilabu, G. Palacios, D. J. Park, J. T. Paweska, S. R. Radoshitzky, C. A. Rossi, P. C. Sabeti, J. S. Schieffelin, R. J. Schoepp, R. Sealfon, R. Swanepoel, J. S. Towner, J. Wada, N. Wauquier, N. L. Yozwiak, P. Formenty, Nomenclature- and database-compatible names for the two Ebola virus Variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses 6, 4760-4799 (2014).
5. P. H. Kilmarx, K. R. Clarke, P. M. Dietz, M. J. Hamel, F. Husain, J. D. McFadden, B. J. Park, D. E. Sugerman, J. S. Bresee, J. Mermin, J. McAuley, A. Jambai, Ebola virus disease in health care workers-Sierra Leone 2014. MMWR Morb. Mortal. Wkly. Rep. 63, 1168-1171 (2014).
6. X. Qiu, G. Wong, J. Audet, A. Bello, L. Fernando, J. B. Alimonti, H. Fausther-Bovendo, H. Wei, J. Aviles, E. Hiatt, A. Johnson, J. Morton, K. Swope, O. Bohorov, N. Bohorova, C. Goodman, D. Kim, M. H. Pauly, J. Velasco, J. Pettitt, G. G. Olinger, K. Whaley, B. Xu, J. E. Strong, L. Zeitlin, G. P. Kobinger, Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53 (2014).
7. G. G. Olinger Jr., J. Pettitt, D. Kim, C. Working, O. Bohorov, B. Bratcher, E. Hiatt, S. D. Hume, A. K. Johnson, J. Morton, M. Pauly, K. J. Whaley, C. M. Lear, J. E. Biggins, C. Scully, L. Hensley, L. Zeitlin, Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques., Proc. Natl. Acad. Sci. U. S. A. 109, 18030-18035 (2012).
8. X. Qiu, J. Audet, G. Wong, S. Pillet, A. Bello, T. Cabral, J. E. Strong, F. Plummer, C. R. Corbett, J. B. Alimonti, G. P. Kobinger, Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4, 138ra81 (2012).
9. G. M. Lyon, a. K. Mehta, J. B. Varkey, K. Brantly, L. Plyler, A. K. McElroy, C. S. Kraft, J. S. Towner, C. Spiropoulou, U. Ströher, T. M. Uyeki, B. S. Ribner; Emory Serious Communicable Diseases Unit, Clinical care of two patients with Ebola virus disease in the United States. N. Engl. J. Med. 371, 2402-2409 (2014).
10. G. Wong, G. P. Kobinger, Backs against the wall: Novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin. Microbiol. Rev. 28, 593-601 (2015).
11. NIAID, Putative Investigational Therapeutics in the Treatment of Patients with Known Ebola Infection, ClinicalTrials.gov (available at www.clinicaltrials.gov/ct2/show/NCT02363322? term=Zmapp&rank=1) (2015).
12. A. Hiatt, N. Bohorova, O. Bohorov, C. Goodman, D. Kim, M. H. Pauly, J. Velasco, K. J. Whaley, P. A. Piedra, B. E. Gilbert, L. Zeitlin, Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy. Proc. Natl. Acad. Sci. U. S. A. 111, 5992-5997 (2014).
13. X. Qiu, J. B. Alimonti, P. L. Melito, L. Fernando, U. Ströher, S. M. Jones, Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin. Immunol. 141, 218-227 (2011).
14. C. D. Murin, M. L. Fusco, Z. Bornholdt, X. Qiu, G. G. Olinger, L. Zeitlin, G. P. Kobinger, A. B. Ward, E. O. Saphire, Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc. Natl. Acad. Sci. U. S. A. 111, 17182-17187 (2014).
15. J. Audet, G. Wong, H. Wang, G. Lu, G. F. Gao, G. Kobinger, X. Qiu, Molecular characterization of the monoclonal antibodies composing ZMAb: A protective cocktail against Ebola virus. Sci. Rep. 4, 6881 (2014).
16. S. Bale, J. M. Dias, M. L. Fusco, T. Hashiguchi, A. C. Wong, T. Liu, A. I. Keuhne, S. Li, V. L. Woods Jr., K. Chandran, J. M. Dye, E. O. Saphire, Structural basis for differential neutralization of ebolaviruses. Viruses 4, 447-470 (2012).
17. A. Marzi, R. Yoshida, H. Miyamoto, M. Ishijima, Y. Suzuki, M. Higuchi, Y. Matsuyama, M. Igarashi, E. Nakayama, M. Kuroda, M. Saijo, F. Feldmann, D. Brining, H. Feldmann, A. Takada, Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLOS One 7, e36192 (2012).
18. S. Fink, "A Chinese Ebola drug raises hopes, and rancor", New York Times, A9 (2015).
19. S. Mundasad, "British medic declared free of Ebola", BBC News (available at www.bbc.com/news/health-32088310) (2015).
20. J. M. Dias, A. I. Kuehne, D. M. Abelson, S. Bale, A. C. Wong, P. Halfmann, M. A. Muhammad, M. L. Fusco, S. E. Zak, E. Kang, Y. Kawaoka, K. Chandran, J. M. Dye, E. O. Saphire, A shared structural solution for neutralizing ebolaviruses. Nat. Struct. Mol. Biol. 18, 1424-1427 (2011).
21. J. Pettitt, L. Zeitlin, D. H. Kim, C. Working, J. C. Johnson, O. Bohorov, B. Bratcher, E. Hiatt, S. D. Hume, A. K. Johnson, J. Morton, M. H. Pauly, K. J. Whaley, M. F. Ingram, A. Zovanyi, M. Heinrich, A. Piper, J. Zelko, G. G. Olinger, Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci. Transl. Med. 5, 199ra113 (2013).
22. L. Zeitlin, J. Pettitt, C. Scully, N. Bohorova, D. Kim, M. Pauly, A. Hiatt, L. Ngo, H. Steinkellner, K. J. Whaley, G. G. Olinger, Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc. Natl. Acad. Sci. U. S. A. 108, 20690-20694 (2011).
23. P. Zhang, R. Haryadi, K. F. Chan, G. Teo, J. Goh, N. A. Pereira, H. Feng, Z. Song, Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant. Glycobiology 22, 897-911 (2012).
24. H. Lin, D. Zelterman, Modeling survival data: Extending the cox model. Technometrics 44, 85-86 (2002).